In 'Episode 2' of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks to Dr. Laura Marandino (GB) about "The first-line treatment strategies for metastatic renal cell carcinoma".

Dr. Andrea Mari and Dr. Laura Marandino unravel the complexities of mRCC management, exploring the latest advancements, therapeutic options, and their implications for patient care. From targeted therapies to immunotherapies, they provide a comprehensive overview of the evolving treatment landscape.

Tune in as we navigate through this insightful conversation with two distinguished guests at the forefront of cancer research and treatment.

This podcast episode was recorded before ASCO GU 2024. Please note that information discussed may not reflect updates from the conference. We encourage listeners to verify the latest information independently.